In a retrospective analysis of clinical trial data, they found that melanoma patients with highly
aneuploid tumors were less likely to benefit from immune checkpoint blockade therapy than patients whose tumors showed fewer chromosomal disruptions.
Not exact matches
Pre-malignant
aneuploid cells grew more slowly and formed smaller
tumors than comparable cells with normal chromosome number.»
Moreover, many human
tumors have highly abnormal numbers of chromosomes (that is, they are
aneuploid), with initial chromosomal loss participating in the early steps of the transformation cascade in inherited cancers caused by heterozygous mutation in
tumor suppressor genes and the more widespread aneuploidy characteristic of advance
tumors thought to drive acquisition of malignant growth properties.??
Wing primordia subjected to CIN are characterised by
tumor - like overgrowths, metastatic behavior and malignancy to the host upon blockade of the apoptotic machinery, and this tumorigenic response relies mainly on the production of highly
aneuploid cells that delaminate from the epithelium and activate a JNK - dependent transcriptional response.
Using a series of genetically - matched euploid and
aneuploid cell lines, we have demonstrated that aneuploidy can paradoxically function as a barrier to
tumor growth.
By identifying phenotypes that are shared among
tumors with different aneuploidies, we hope to discover pathways that can be manipulated to selectively eliminate
aneuploid cells or to block aneuploidy's non-cell autonomous effects.
Pre-malignant
aneuploid cells grew more slowly and formed smaller
tumors than comparable cells with normal chromosome number, CSHL researchers found...